Omega-3 Fatty Acids in Depression: A Systematic Review of Human Studies with Supporting Evidence from Preclinical Models
Abstract
Background: Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are essential for brain function and have been increasingly studied for their potential preventive and therapeutic roles in depression. Methods: A systematic review was conducted in accordance with PRISMA guidelines, focusing on recent human studies evaluating the effects of n-3 PUFA supplementation and Mediterranean dietary patterns on depression-related outcomes. Studies were identified through electronic databases and manual searches and critically appraised using the Joanna Briggs Institute Checklist for Randomized Controlled Trials. To contextualize human data, relevant preclinical animal studies were also reviewed. Results: The review identified mixed and context-dependent evidence for the efficacy of n-3 PUFAs in depression prevention among general populations. In contrast, more consistent therapeutic effects were observed in treatment studies, particularly when EPA-predominant formulations were used as adjunctive interventions. However, many studies lacked statistical power or did not achieve significance. Six preclinical studies demonstrated robust antidepressant and anxiolytic effects of EPA and DHA across models of nicotine withdrawal, chronic stress, aging, and neurotrophin deficiency. These effects were linked to anti-inflammatory, neuroprotective, and neurotrophic mechanisms. Conclusions: Omega-3 PUFAs—especially EPA—may offer modest yet clinically relevant benefits as adjunctive treatments for…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.